Monday, 20 May 2019

BioTech News

  • Progress achieved in obesity vaccine research

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2012

    Singapore: Though still some years away from clinical development in humans, a new study conducted at Braasch Biotech, a US-based company, has shown in mice that a prohphylatic vaccine for ...Read more

  • US, EU, Aussie and Canada together churn $98.8 bn biotech revenue in 2013: EY

    BioTech |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit revenue growth and a sharp increase in funds raised, according to Ernst &am...Read more

  • DynoChem bio-software makes way into China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    Singapore: Scale-up Systems, a leading provider of process development software to the pharmaceutical industry, entered into a multi-year agreement with ScienView, a fast-growing life scien...Read more

  • Japan approves pioneering stem cell study for heart disease

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    Singapore: Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical study in Japan using the Celution System has been approved under the Min...Read more

  • A*STAR scientists identify potential drug target for inflammatory diseases including cancers

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause f...Read more

  • Regenerative Therapy for heart failure enters Ph III Trial

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal Agency for Medicines and Health Products (FAMHP) to begin its Congest...Read more

  • Asia has potential in NGS research: Dr Partha Majumdar

    BioTech |  Influencers | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2012

    Dr Partha Majumder is a principal investigator representing India in the International Cancer Genome Consortium, focussing on oral cancer as a part of the ICGC activities, particularly the ...Read more

  • RegeneRx Chinese heart patent gets nod

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

    Singapore: RegeneRx Biopharmaceuticals has received a Notice of Allowance of a Chinese patent application for uses of Thymosin beta 4 (TB4) for treating, preventing, inhibiting or reducing...Read more

  • Accelrys to shut plant, slash 12 percent of its staff

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Accelrys is going to slash 12 percent of its workforce and is also going to shut down its San Ramon facility in the US. The restructuring of the firm will be completed by the end...Read more

  • Isogenica appoints CTC Lab Systems to tap Japan

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Isogenica has appointed CTC Laboratory Systems (CTCLS) of Tokyo, Japan, to represent its business in Japan. CTCLS is a leading force in the pharmaceutical research market in Japa...Read more

  • Chinese agritech facility to employ world's largest corn husker

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Xinjiang Origin, a subsidiary of Origin Agritech, held an opening ceremony for its regional corn seed processing facility at Bole, Xinjiang, China. Origin Agritech is a technolo...Read more

  • Taiwan firm NCE to get priority review in China

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into the "Green Path" program by the Chinese State Food and Drug Administr...Read more

  • Phylogica extends collaboration with Janssen Biotech

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

    Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen Biotech and its affiliates to discover, develop and commercialize new ...Read more

  • Biocon insulin study gives positive results

    BioTech |  Company results | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

    Bangalore: The global phase III study for Biocon's recombinant human insulin (Insugen(R)), in Type 1 diabetes mellitus patients, has demonstrated comparable safety and efficacy with the inn...Read more

  • Novartis MenB vaccine gets approval in Australia

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2013

    Singapore: Australian Therapeutic Goods Administration (TGA) has approved Novartis' Bexsero, a multi-component Meningococcal B (MenB) vaccine (recombinant, adsorbed) suspension for injectio...Read more

  • Taipei launches biotech development consortium

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2013

    Singapore: Taipei City Government has inaugurated the biotech development consortium in Banqiao District, in northern Taiwan, thus strengthening Taipei's positioning in the biotech industry...Read more

  • Universal gets $250k tech implementation vouchers

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 15 Apr, 2013

    Singapore: Universal Biosensors, developer of cardiac marker biosensor, is one-of-the-seven firms to receive Technology Implementation Vouchers totalling $250,000. Mr Gordon Rich-Phillips,...Read more

  • Sartorius to acquire TAP Biosystems

    BioTech |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2013

    Singapore: Sartorius Stedim Biotech, a biosupplier giant for the pharmaceutical and biotech industries, plans to acquire UK company TAP Biosystems Group. The proposed transaction, which is...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls